Pacific Trader: How AbCellera's stock can make a full recovery - BCBusiness
AbCellera Reports Q3 2022 Business Results
Covid-19 Treatment Developer AbCellera Biologics Files for IPO - Bloomberg
AbCellera Reports Full Year 2022 Business Results, Revenue up 29.3% to US $485 Million | T-Net News
Beyond COVID-19: AbCellera Partners with Moderna to Develop mRNA-Encoded Antibodies
Team
This College Professor Became An Overnight Billionaire Fighting Covid
AbCellera Reports Q3 2022 Business Results
E(WHY) Talks interview – Carl Hansen | EY Canada
AbCellera is not a COVID-19 company, CEO insists, even as Canadian developer reaps windfall from pandemic treatments - The Globe and Mail
AbCellera Biologics Inc. - AbCellera Reports Q1 2023 Business Results
AbCellera CEO on raising $105 million in series B funding
The American Billionaires Too Poor To Make The 2021 Forbes 400 List
Visionary biotech player Carl Hansen of AbCellera named Canada's EY Entrepreneur Of The Year® 2021 | EY Canada
Carl Hansen - Chief Executive Officer - AbCellera | LinkedIn
Team
Meet The 50 Doctors, Scientists And Healthcare Entrepreneurs Who Became Pandemic Billionaires In 2020
Meet Carl Hansen, the scientist-turned-CEO behind AbCellera's life-saving COVID-19 treatment - The Globe and Mail
AbCellera Reports Full Year 2021 Business Results
S-1
Carl Hansen, AbCellera CEO sits down with Fierce Biotech's Rebecca Willumson - AbCellera
Carl Hansen, AbCellera CEO sits down with Fierce Biotech's Rebecca Willumson - AbCellera
EY World Entrepreneur Of The Year™ Class of 2022, Canada
A transition to translation: Dr. Carl Hansen
Meet Carl Hansen, the scientist-turned-CEO behind AbCellera's life-saving COVID-19 treatment - The Globe and Mail
S-1
Sunday Briefing | #120 - by William Johnson
